Phase I/II Study of 5-Azacytidine With Ara-C in Patients With Relapsed/Refractory Acute Myelogenous Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)
PHASE1
The goal of this clinical research study is to find the highest tolerable d...
A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy
PHASE1
This Phase Ia/Ib, open-label, multicenter study will evaluate the safety, t...
Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies
PHASE1
Background:
Previously we have demonstrated induction of tumor antigen and...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike